Document is current
Any future updates will be listed below
-
Authors
Zhao, Yuyang
Niu, Xiaokang
Zhang, Yong
Zhao, Liang
Zhang, Liwei
He, Jingjing
Zhang, Qi
Mao, Yuejian
Wang, Fuqing
Zhao, Xiaohui
Wang, Ran
-
Funding
Funding for this research was provided by:
National Key Research and Development Program of China (2022YFF1100100, 2022YFF1100100, 2022YFF1100100)
- License Information
-
More Information
Article History
Received: 6 November 2024
Accepted: 2 April 2025
First Online: 7 July 2025
Declarations
:
: This study was registered with the Chinese Clinical Trial Registry (registration number: ChiCTR220059817) and was approved by the Medical Ethics Committee of The First Medical Center of Chinese PLA General Hospital (approval number: S2022–060–02). This study was conducted in accordance with the principles of good clinical practice and the Declaration of Helsinki. All participants voluntarily signed a written informed consent form after fully understanding the potential benefits and risks of participating in the trial.
: All study subjects gave their written informed consent that their data could be used for publications in anonymized form.
: The authors declare no competing interests.
